Osteoporos Int 19 May online 2015. DOI 10.1007/s00198-015-3160-8
Postmenopausal women aged 50 years and older with a recent DRF had lower bone and muscle strength in both the upper and lower extremities com- pared to the women without a recent DRF, despite no differences in DXA-derived aBMD at the femoral neck or spine and no difference in bone strength at the tibia shaft. Although DXA is clinically used for diagnosing osteoporosis in individual patients, this study provides further support for the notion that aBMD alone may not provide a sufficient predictor for DRF risk.
Autor: K. Crockett, C. M. Arnold, J. P. Farthing, P. D. Chilibeck, J. D. Johnston, B. Bath,A. D. G. Baxter-Jones,S. A. Kontulainen.